Skip to Main Content
Insider Trading

Jamie L. Reynoso Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 3 weeks, 5 days ago

Jamie L. Reynoso has an estimated net worth of at least $11.0 million*, as of Oct. 29, 2025. They own 2.8 million shares of CLOV stock. They have sold 102,899 shares of CLOV stock since 2021, for an estimated $199,934.

Jamie L. Reynoso $CLOV SEC Form 4 Insider Trading

Jamie L. Reynoso has filed a total of 8 insider trades in $CLOV since 2021. Their most recent trade was a sale of 30,385 shares, made on Nov 04, 2025. Their largest trade was a sale of 30,385 shares, made on Nov 04, 2025. We estimate that they now own 2.8 million shares of $CLOV, worth an estimated $10.8 million.



Insider Trading at $CLOV

There have been a total of 30 insider trades reported at $CLOV since 2021, with 4.0 million shares purchased and 640,196 shares sold. The most active insider traders in $CLOV stock have been Jamie L. Reynoso, Conrad Wai, and Brady Patrick Priest. The most recent trade was a sale of 30,385 shares reported by Jamie L. Reynoso (CEO, Medicare Advantage), made on Nov 04, 2025.



History of Insider Stock Trades by Jamie L. Reynoso

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
CLOV logo CLOV Sale 30,385 Nov 04, 2025 Nov. 5, 2025, 5:46 p.m.
CLOV logo CLOV Sale 16,514 Oct 17, 2025 Oct. 21, 2025, 4:09 p.m.
CLOV logo CLOV Sale 2,012 Oct 07, 2025 Oct. 7, 2025, 4:37 p.m.
CLOV logo CLOV Sale 4,914 Sep 17, 2025 Sept. 19, 2025, 4:13 p.m.
CLOV logo CLOV Sale 6,823 Aug 04, 2025 Aug. 6, 2025, 4:59 p.m.
CLOV logo CLOV Sale 2,012 Jul 07, 2025 July 8, 2025, 5:15 p.m.
CLOV logo CLOV Sale 19,789 Jul 03, 2025 July 8, 2025, 5:15 p.m.
CLOV logo CLOV Sale 20,450 Jun 17, 2025 June 18, 2025, 5:26 p.m.




$CLOV Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.